KALA
Price
$3.20
Change
+$0.02 (+0.63%)
Updated
Apr 28, 02:28 PM (EDT)
Capitalization
20.52M
SIGY
Price
$3.53
Change
-$0.62 (-14.94%)
Updated
Apr 25 closing price
Capitalization
5.67M
Ad is loading...

KALA vs SIGY

Header iconKALA vs SIGY Comparison
Open Charts KALA vs SIGYBanner chart's image
Kala BIO
Price$3.20
Change+$0.02 (+0.63%)
Volume$100
Capitalization20.52M
Sigyn Therapeutics
Price$3.53
Change-$0.62 (-14.94%)
Volume$300
Capitalization5.67M
KALA vs SIGY Comparison Chart
Loading...
KALA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KALA vs. SIGY commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KALA is a Buy and SIGY is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (KALA: $3.18 vs. SIGY: $3.53)
Brand notoriety: KALA and SIGY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KALA: 97% vs. SIGY: 101%
Market capitalization -- KALA: $20.52M vs. SIGY: $5.67M
KALA [@Biotechnology] is valued at $20.52M. SIGY’s [@Biotechnology] market capitalization is $5.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KALA’s FA Score shows that 0 FA rating(s) are green whileSIGY’s FA Score has 0 green FA rating(s).

  • KALA’s FA Score: 0 green, 5 red.
  • SIGY’s FA Score: 0 green, 5 red.
According to our system of comparison, SIGY is a better buy in the long-term than KALA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KALA’s TA Score shows that 5 TA indicator(s) are bullish.

  • KALA’s TA Score: 5 bullish, 4 bearish.

Price Growth

KALA (@Biotechnology) experienced а -7.96% price change this week, while SIGY (@Biotechnology) price change was -14.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.39%. For the same industry, the average monthly price growth was +0.39%, and the average quarterly price growth was -9.83%.

Reported Earning Dates

KALA is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Biotechnology (+10.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KALA($20.5M) has a higher market cap than SIGY($5.67M). SIGY YTD gains are higher at: 12.063 vs. KALA (-54.179). SIGY has higher annual earnings (EBITDA): -2.65M vs. KALA (-32.84M). KALA has more cash in the bank: 49.2M vs. SIGY (165K). SIGY has less debt than KALA: SIGY (1.93M) vs KALA (37M). KALA (0) and SIGY (0) have equivalent revenues.
KALASIGYKALA / SIGY
Capitalization20.5M5.67M362%
EBITDA-32.84M-2.65M1,239%
Gain YTD-54.17912.063-449%
P/E RatioN/AN/A-
Revenue00-
Total Cash49.2M165K29,818%
Total Debt37M1.93M1,914%
FUNDAMENTALS RATINGS
KALA vs SIGY: Fundamental Ratings
KALA
SIGY
OUTLOOK RATING
1..100
6050
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
9763
P/E GROWTH RATING
1..100
9798
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KALA's Valuation (50) in the Pharmaceuticals Major industry is in the same range as SIGY (50) in the null industry. This means that KALA’s stock grew similarly to SIGY’s over the last 12 months.

KALA's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as SIGY (100) in the null industry. This means that KALA’s stock grew similarly to SIGY’s over the last 12 months.

KALA's SMR Rating (99) in the Pharmaceuticals Major industry is in the same range as SIGY (100) in the null industry. This means that KALA’s stock grew similarly to SIGY’s over the last 12 months.

SIGY's Price Growth Rating (63) in the null industry is somewhat better than the same rating for KALA (97) in the Pharmaceuticals Major industry. This means that SIGY’s stock grew somewhat faster than KALA’s over the last 12 months.

KALA's P/E Growth Rating (97) in the Pharmaceuticals Major industry is in the same range as SIGY (98) in the null industry. This means that KALA’s stock grew similarly to SIGY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KALA
RSI
ODDS (%)
Bullish Trend 4 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
70%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
82%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
KALA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDESX32.730.19
+0.58%
Fidelity Advisor Diversified Stock O
ASIMX12.110.05
+0.41%
Alger Weatherbie Specialized Growth I
AMFCX53.370.10
+0.19%
American Funds American Mutual C
BRKRX13.910.02
+0.14%
MFS Blended Research Em Mkts Eq R1
AGGNX17.92-0.32
-1.75%
American Century Global Gold I

KALA and

Correlation & Price change

A.I.dvisor tells us that KALA and PALI have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KALA and PALI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KALA
1D Price
Change %
KALA100%
-3.64%
PALI - KALA
31%
Poorly correlated
-2.11%
ARDX - KALA
28%
Poorly correlated
+4.78%
ENTX - KALA
27%
Poorly correlated
+2.13%
ORIC - KALA
27%
Poorly correlated
-1.73%
CRGX - KALA
27%
Poorly correlated
-0.33%
More

SIGY and

Correlation & Price change

A.I.dvisor tells us that SIGY and OTLK have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SIGY and OTLK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIGY
1D Price
Change %
SIGY100%
-14.94%
OTLK - SIGY
23%
Poorly correlated
-1.29%
ACHV - SIGY
21%
Poorly correlated
-1.67%
KALA - SIGY
21%
Poorly correlated
-3.64%
CSPHF - SIGY
8%
Poorly correlated
N/A
CPMV - SIGY
6%
Poorly correlated
N/A
More